Alport Syndrome clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)
Sorry, in progress, not accepting new patients
This study is a proof-of-concept trial of vonafexor safety, its effects on kidney function in subjects with at risk of progression Alport syndrome.
Los Angeles 5368361, California 5332921 and other locations